QualityStocksNewsBreaks Archives - Page 447 of 1538

WednesdayDec 21, 2022 1:19 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Releases Fiscal Year 2022 Report, Featured in CBC News Interview

SideChannel Inc. (OTCQB: SDCH), a provider of cybersecurity services and technology for emerging and middle market companies, reported on its fiscal year ended Sept. 30, 2022. Highlights of the report include revenue for the company reaching $4.8 million, a 71% increase over 2021, with vCISO revenue totaling $3.1 million, an increase of 93% over 2021. SideChannel’s recurring vCISO revenue reportedly increased by 562% and recurring software and services revenue increased by 367%. “Our 2022 performance demonstrates our continued strength and position in the market across both product and service delivery,” said SideChannel CEO Brian Haugli in the press release. “Our investments…

WednesdayDec 21, 2022 10:37 am

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Recaps 2022 as a Tremendous Year of Technology and Milestones

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a clean technology company developing transformative power conversion technologies and control system solutions for next-generation electrical systems, today issued a recap of the significant progress achieved by the company during the year. “2022 has been a tremendous year for Hillcrest, as the company met or exceeded every milestone we set out to achieve. We are proud of the incredible progress made thus far,” said Hillcrest CEO Don Currie. “We entered the year with a proof of concept for our core technology, the Hillcrest ZVS inverter technology, and progressed through design, commissioning and finally completion of…

TuesdayDec 20, 2022 3:23 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Dosing in Its Human Oral Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that dosing has begun in its human clinical nicotine study NIC-H22-1. Current cigarette smokers are participating in the 36-person human pharmacokinetic randomized, double blinded, cross-over study, wherein each person will visit the laboratory to be dosed three times over the coming weeks. Only one oral nicotine pouch (DehydraTECH-nicotine, On! brand manufactured by Altria, or Zyn brand manufactured by Swedish Match) will be administered and evaluated during each visit. The primary objectives are to determine the quantity of nicotine in blood at various time points and collection…

TuesdayDec 20, 2022 2:21 pm

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Closes $8M Underwritten Public Offering

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced the closing of its underwritten public offering with gross proceeds to the company to be $8,000,000. The offering consists of 1,600,000 units and pre-funded units, with each unit consisting of one American Depositary Share (“ADS”) and two warrants, each to purchase one ADS. Each pre-funded unit consists of one pre-funded warrant to purchase one ADS and two warrants each to purchase one ADS. BiondVax expects to use the net proceeds, together with its existing…

TuesdayDec 20, 2022 1:33 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Featured in Built in Boston Article

SideChannel (OTCQB: SDCH) was featured in a recent article published by Built in Boston, the online community for Boston startups and tech companies. The piece discusses SideChannel’s success in growing its revenue by 114% over the past year and its business strategy of renting chief information security officers(“CISOs”) to startups. “Worcester-based SideChannel’s mission is to give every company access to the benefits of having a CISO without the cost of a full-time hire. The cybersecurity company evaluates an organization’s needs and matches the business with a virtual chief information security officer (‘vCISO’) that has enterprise-level experience,” the article reads. Further…

TuesdayDec 20, 2022 12:43 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Retention of Third Company in Investigation of Potential Naked Short Selling

FingerMotion (NASDAQ: FNGR), a mobile data and services company, has entered into a service agreement with ShareIntel-Shareholder Intelligence Services. The agreement outlines ShareIntel’s assistance in reviewing the trading history of FingerMotion’s common stock for the past two years as well as tracking trading of the stock moving forward; ShareIntel will assist the Christian Levine Law Group and Warshaw Burstein LLP, which have each already been retained by FingerMotion. According to the announcement, ShareIntel uses DRIL-Down(TM), a patented process that aggregates and analyzes repository data from reporting entities, broker-dealers and shareholders; the process will support FingerMotion in its efforts to proactively track…

TuesdayDec 20, 2022 12:07 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) to Participate in 21st Annual J.P. Morgan Tech/Auto Forum

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, today announced that its Chief Executive Officer Dr. Jun Pei and Chief Financial Officer Hull Xu will be participating in the 21st Annual J.P. Morgan Tech/Auto Forum. The forum is slated to take place at the Bellagio Hotel during CES 2023 in Las Vegas, Nevada, on Jan. 5, 2023. Cepton will participate in a fireside chat at the event at 2:20 p.m. PT on Thursday, Jan. 5. Interested parties should visit https://ibn.fm/2Sfvm to view a live audio webcast of the presentation. To view the full press release,…

TuesdayDec 20, 2022 11:59 am

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Files Updated Life Sciences Presentation

India Globalization Capital (NYSE American: IGC) today announced the filing of a life sciences presentation with the SEC on Form 8K. The presentation, available on the SEC website as well as published to IGC’s website, provides an overview of the company’s initiatives in life sciences. These include IGC’s focus on low-dose THC-based drug formulation and disease treatment and its various lines of cannabinoid-based consumer products. To view the full press release, visit https://ibn.fm/n3Fm6 About India Globalization Capital Inc. India Globalization Capital, through its subsidiary IGC Pharma LLC, develops advanced cannabinoid-based formulations for treating diseases, including but not limited to Alzheimer’s,…

TuesdayDec 20, 2022 11:35 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Wraps Up 2022 Mullen FIVE Strikingly Different Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, finished its innovative 2022 Mullen FIVE Strikingly Different Test Drive Tour with a last stop on Dec. 16, 2022, in Charlotte, North Carolina. The tour began Oct. 27, 2022, and featured stops in nine cities in the west, south, and southeastern parts of the country. According to the announcement, the tour was very successful; the company is already planning a follow-up spring tour with stops planned throughout the eastern, northwest and Midwest parts of the country. The fall tour featured the Mullen Five; the spring tour will feature the Mullen…

TuesdayDec 20, 2022 11:12 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO Highlights 2022 as ‘Momentous Year’

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today issued a year-end summary of its key milestone accomplishments in 2022. “2022 was a momentous year marked by steady progress across our pipeline of differentiated psychedelic-based therapeutics and partnerships targeting mental health. Most notable were the advancements of our two lead programs, CYB003 and CYB004, into clinical stage – within less than 18 months since discovery – which is a remarkable accomplishment and a true testament to the strength of our team,” said Cybin’s Chief Executive Officer Doug Drysdale. “Along with our clinical programs,…

Site Search

Company Search

Category: QualityStocksNewsBreaks